MedTrace Logo

Brain Stimulation for the Treatment of Tourette Syndrome

NCT01329198 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2018-06-08

Study results available
· View outcomes & findings →

Summary

The purpose of this trial is to determine whether a particular type of Deep Brain Stimulation (DBS), scheduled Deep Brain stimulation (SBS), is an effective and safe treatment for Tourettte syndrome (TS).

The trial will also examine the brain activity associated with TS and tics and explore the possibility of responsive brain stimulation (RBS).

Conditions

  • Tourette Syndrome

Interventions

DEVICE

NeuroPace RNS® System Deep Brain Stimulator

Utilizes a signal that the device detects and will respond to with an electrical pre-defined pulse if the signal is encountered.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Michael Okun, MD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-11-30
Completion
2017-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01329198 on ClinicalTrials.gov